Aug 26, 2024 / 09:00AM GMT
Klas Palin - Penser Access(Commissioned)-Analyst
Hello, and welcome to Carnegie and today's presentation with Senzime and its Q2 report. My name is Klas Palin, and I'm an equity analyst. And with me in the studio, I have Philip Siberg, who is CEO of Senzime. Very welcome, Philip.
Philip Siberg - Senzime AB - Chief Executive Officer
Thank you. Nice to be here.
Klas Palin - Penser Access(Commissioned)-Analyst
And it would be really interesting to hear your presentation of the Q2 report. Please go ahead, Philip.
Philip Siberg - Senzime AB - Chief Executive Officer
All right. Thank you, and thank you for listening-in into this. It's both a Q2 report, but also a little bit of an update today on some of our long- and short-term guidance and what we believe in the market. So for those of you who don't know Senzime, a quick recap. We are a Sweden headquartered medical device company.
We've developed a
Q2 2024 Senzime AB (publ) Earnings Call Transcript
Aug 26, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers